A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
View ORCID ProfileMatthew M. Hernandez, Radhika Banu, Paras Shrestha, View ORCID ProfileAna S. Gonzalez-Reiche, Adriana van de Guchte, Keith Farrugia, Robert Sebra, Mount Sinai PSP Study Group, Melissa R. Gitman, Michael D. Nowak, Carlos Cordon-Cardo, View ORCID ProfileViviana Simon, View ORCID ProfileHarm van Bakel, View ORCID ProfileEmilia Mia Sordillo, Nicolas Luna, Angie Ramirez, Sergio Andres Castañeda, Luz Helena Patiño, Nathalia Ballesteros, Marina Muñoz, View ORCID ProfileJuan David Ramírez, View ORCID ProfileAlberto E. Paniz-Mondolfi
doi: https://doi.org/10.1101/2022.05.28.22275691
Matthew M. Hernandez
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Radhika Banu
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Paras Shrestha
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Ana S. Gonzalez-Reiche
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Adriana van de Guchte
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Keith Farrugia
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Robert Sebra
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
4Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
5Sema4, a Mount Sinai venture, Stamford, CT 06902, USA
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
Melissa R. Gitman
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Michael D. Nowak
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Carlos Cordon-Cardo
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Viviana Simon
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
7Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
8Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
9The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Harm van Bakel
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
3Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Emilia Mia Sordillo
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Nicolas Luna
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Angie Ramirez
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Sergio Andres Castañeda
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Luz Helena Patiño
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Nathalia Ballesteros
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Marina Muñoz
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Juan David Ramírez
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
10Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
Alberto E. Paniz-Mondolfi
1Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
Data Availability
All single variant consensus genome sequences were deposited in the publicly-available Global Initiative on Sharing Avian Influenza Data (GISAID) database (www.gisaid.org) [accession identifiers indicated in Table S4]. The remaining 10 genomes with mixed patters of mutations were not deposited into GISAID as single variant consensus genomes could not be resolved (data available upon request).
Posted May 29, 2022.
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
Matthew M. Hernandez, Radhika Banu, Paras Shrestha, Ana S. Gonzalez-Reiche, Adriana van de Guchte, Keith Farrugia, Robert Sebra, Mount Sinai PSP Study Group, Melissa R. Gitman, Michael D. Nowak, Carlos Cordon-Cardo, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Nicolas Luna, Angie Ramirez, Sergio Andres Castañeda, Luz Helena Patiño, Nathalia Ballesteros, Marina Muñoz, Juan David Ramírez, Alberto E. Paniz-Mondolfi
medRxiv 2022.05.28.22275691; doi: https://doi.org/10.1101/2022.05.28.22275691
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
Matthew M. Hernandez, Radhika Banu, Paras Shrestha, Ana S. Gonzalez-Reiche, Adriana van de Guchte, Keith Farrugia, Robert Sebra, Mount Sinai PSP Study Group, Melissa R. Gitman, Michael D. Nowak, Carlos Cordon-Cardo, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Nicolas Luna, Angie Ramirez, Sergio Andres Castañeda, Luz Helena Patiño, Nathalia Ballesteros, Marina Muñoz, Juan David Ramírez, Alberto E. Paniz-Mondolfi
medRxiv 2022.05.28.22275691; doi: https://doi.org/10.1101/2022.05.28.22275691
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2848)
- Dermatology (244)
- Emergency Medicine (429)
- Epidemiology (12558)
- Forensic Medicine (10)
- Gastroenterology (805)
- Genetic and Genomic Medicine (4432)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4192)
- Nursing (222)
- Nutrition (617)
- Oncology (2203)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (483)
- Public and Global Health (6779)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)